Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 919 questions Show Answers
To ask the Scottish Government how it will ensure that GPs make information on rheumatoid arthritis available to the public.
To ask the Scottish Government what assessment it has made of the need for coordination between local authorities, the NHS and social care services to ensure that services for people diagnosed with rheumatoid arthritis are fully integrated.
To ask the Scottish Government what recent assessment it has made of the effectiveness of the management by multidisciplinary teams of (a) rheumatoid arthritis, (b) ankylosing spondylitis and (c) psoriatic arthritis.
To ask the Scottish Government how many people with severe rheumatoid arthritis who would benefit from anti-tumour necrosis factor (anti-TNF) therapy do not receive it, and whether it will ensure that anti-TNF treatment will be made available on prescription to all patients where the clinical diagnosis supports such treatment.
To ask the Scottish Government how it will ensure that GPs have greater awareness of rheumatoid arthritis to enable earlier identification of the disease.
To ask the Scottish Government how many finished episodes of care there have been for patients with a (a) primary and (b) secondary diagnosis of rheumatoid arthritis in each year since 2007.
To ask the Scottish Government what steps it is taking to improve the training provided to GPs in respect of rheumatoid arthritis; what funding it provides to support this training, and when educational material that supports this will be provided.
To ask the Scottish Government which NHS boards have not yet made treatment approved by the Scottish Medicines Consortium or the National Institute for Health and Clinical Excellence (NICE) for use in rheumatoid arthritis available to people with a clinical need and what assessment it has made of the potential impact of any NHS deficits on the uptake of treatment approved by NICE for use in rheumatoid arthritis.
To ask the Scottish Government (a) how much it cost (i) the NHS and (ii) social services to provide services to people diagnosed with rheumatoid arthritis, (b) how many new cases of rheumatoid arthritis were diagnosed and (c) how many people were recorded as having rheumatoid arthritis in each NHS board area, in the most recent year for which figures are available.
To ask the Scottish Government what progress it has made in reviewing evidence on the need for better access to flare-up and pain management services for people with rheumatoid arthritis and when it will produce an action plan.